RecruitingNCT05963841

NUclear MEdicine DIagnostic and Artificial Intelligence

Contribution to Disease Diagnosis and Prognosis Based on the Fusion of Expert Knowledge, Nuclear Medicine Imaging and Artificial Intelligence (AI) Tools

Sponsor

Centre Hospitalier Universitaire de Besancon

Enrollment

1 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Hyperparathyroidism

Summary

Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools. Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline). Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
No refusal to use data for research purposes
Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data

Exclusion Criteria2

Patient refusal to use data for research purposes
Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)

Interested in this trial?

Get notified about updates and connect with the research team.